Cáncer de mama precoz: el caso de la neoadyuvancia en HER2 positivo - page 9

pCR vs EFS & OS

Broglio K, et al. JAMA Oncol 2016

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1,2,3,4,5,6,7,8 10,11,12,13,14,15,16,17,18,19,...47